Physiomics secures follow-on UK contract for Phase 2 study support
RedHill Biopharma reports positive opaganib data in venetoclax-resistant CLL
InduPro secures strategic investment and collaboration with Sanofi to advance autoimmune therapy
Innovent Biologics reports first participant dosed in Phase 1 trial of IBI3011
LabGenius and Sanofi launch AI-driven collaboration on antibody optimisation
Mitsubishi Tanabe Pharma America changes name
Sanofi and Regeneron's Dupixent approved in EU for chronic spontaneous urticaria
Xenogenic Materials Demonstrate Promising Results in Peri-Implantitis Management
European Commission approves Celltrion's Remsima IV liquid formulation
Biotheryx completes enrolment in ongoing Phase 1a trial of BTX-9341 for HR+/HER2- breast cancer
Henlius and Organon secure first US approval for pertuzumab biosimilar POHERDY
CHMP issues positive opinion for DAWNZERA in hereditary angioedema
Longeveron secures US patent for stem cell therapy targeting aging-related frailty